Ebdarokimab Biosimilar - Research Grade

Human

IL12Bï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P29460

Blue ice

The IL-12/IL-23 shared p40 subunit, encoded by IL12B, is a pivotal driver of Th1 and Th17 inflammation and a validated target across autoimmune disease research. Our anti-human IL-12/23 p40 recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of ebdarokimab, distributed for research use only (RUO). Crafted to rigorous in vivo standards, this ultra-pure, low-endotoxin preparation is produced in scalable milligram (mg) to gram (g) quantities for heavy-usage, high-throughput laboratories. It supports neutralization assays, in vitro cytokine-signaling screens, and in vivo models of immune-mediated inflammation, serving as a steady reference reagent throughout.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks